Melanoma Therapeutics Market Analysis By Therapy, By Drugs (Opdivo, Yervoy, Mekinist+Tafinlar, Keytruda, Cotellic, Zelboraf, Imlygic, Generics), And Segment Forecasts, 2018 - 2025

Report ID: GVR-1-68038-535-9
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2014 - 2016
Industry:Healthcare

Market Segmentation

Melanoma Therapeutics Therapy Outlook (Revenue, USD Million, 2014 - 2025)
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Radiation Therapy
Melanoma TherapeuticsDrugs Outlook (Revenue, USD Million, 2014 - 2025)
- Opdivo
- Yervoy
- Mekinist+Tafinlar
- Keytruda
- Cotellic
- Zelboraf
- Imlygic
- Generic Drugs
Melanoma Therapeutics Regional Outlook (USD Million, 2014 - 2025)
- North America
  - North America Melanoma Therapeutics Market, by Therapy
    - Chemotherapy
    - Immunotherapy
    - Radiation Therapy
    - Targeted Therapy
  - North America Melanoma Therapeutics Market, by Drugs
    - Opdivo
    - Yervoy
    - Mekinist+Tafinlar
    - Keytruda
    - Cotellic
    - Zelboraf
    - Imlygic
    - Generics
  - The U.S.
    - The U.S. Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - The U.S. Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
  - Canada
    - Canada Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - Canada Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
- Europe
  - Europe Melanoma Therapeutics Market, by Therapy
    - Chemotherapy
    - Immunotherapy
    - Radiation Therapy
    - Targeted Therapy
  - Europe Melanoma Therapeutics Market, by Drugs
    - Opdivo
    - Yervoy
    - Mekinist+Tafinlar
    - Keytruda
    - Cotellic
    - Zelboraf
    - Imlygic
    - Generics
  - The U.K.
    - The U.K. Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - The U.K. Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
  - Germany
    - Germany Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - Germany Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
- Asia Pacific
  - Asia Pacific Melanoma Therapeutics Market, by Therapy
    - Chemotherapy
    - Immunotherapy
    - Radiation Therapy
    - Targeted Therapy
  - Asia Pacific Melanoma Therapeutics Market, by Drugs
    - Opdivo
    - Yervoy
    - Mekinist+Tafinlar
    - Keytruda
    - Cotellic
    - Zelboraf
    - Imlygic
    - Generics
  - Japan
    - Japan Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - Japan Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
  - China
    - China Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - China Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
  - India
    - India Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - India Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
- Latin America
  - Latin America Melanoma Therapeutics Market, by Therapy
    - Chemotherapy
    - Immunotherapy
    - Radiation Therapy
    - Targeted Therapy
  - Latin America Melanoma Therapeutics Market, by Drugs
    - Opdivo
    - Yervoy
    - Mekinist+Tafinlar
    - Keytruda
    - Cotellic
    - Zelboraf
    - Imlygic
    - Generics
  - Brazil
    - Brazil Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - Brazil Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
  - Mexico
    - Mexico Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - Mexico Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics
- The Middle East & Africa
  - The Middle East & Africa Melanoma Therapeutics Market, by Therapy
    - Chemotherapy
    - Immunotherapy
    - Radiation Therapy
    - Targeted Therapy
  - The Middle East & Africa Melanoma Therapeutics Market, by Drugs
    - Opdivo
    - Yervoy
    - Mekinist+Tafinlar
    - Keytruda
    - Cotellic
    - Zelboraf
    - Imlygic
    - Generics
  - South Africa
    - South Africa Melanoma Therapeutics Market, by Therapy
      - Chemotherapy
      - Immunotherapy
      - Radiation Therapy
      - Targeted Therapy
    - South Africa Melanoma Therapeutics Market, by Drugs
      - Opdivo
      - Yervoy
      - Mekinist+Tafinlar
      - Keytruda
      - Cotellic
      - Zelboraf
      - Imlygic
      - Generics

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
公司财务业绩

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.